Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Lidocaine for Opioid Refractory Pain
NCT00321347Phase 2Withdrawn
- Sponsor
- San Diego Hospice & Palliative Care
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer pain comparing Lidocaine with Placebo (2 arms). Primary endpoint: Pain Score at 30 minutes. Planned start May 2006; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00321347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321347.